{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T03:06:18Z","timestamp":1777950378556,"version":"3.51.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100005371","name":"Hubei Polytechnic University","doi-asserted-by":"publisher","award":["24xjz33R"],"award-info":[{"award-number":["24xjz33R"]}],"id":[{"id":"10.13039\/501100005371","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"DOI":"10.1007\/s10822-026-00820-7","type":"journal-article","created":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T07:05:15Z","timestamp":1777878315000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Insights into the binding mechanism and structural requirements of LPAR2 antagonists as antifibrotic agents based on homology modeling, molecular docking, prediction of membrane permeability and 3D QSAR"],"prefix":"10.1007","volume":"40","author":[{"given":"Ying","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guifu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Puhua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,5,4]]},"reference":[{"key":"820_CR1","doi-asserted-by":"publisher","first-page":"3519","DOI":"10.7150\/jca.41841","volume":"11","author":"H Xiang","year":"2020","unstructured":"Xiang H, Lu Y, Shao M et al (2020) Lysophosphatidic acid receptors: biochemical and clinical implications in different diseases. J Cancer 11:3519\u20133535","journal-title":"J Cancer"},{"key":"820_CR2","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s11010-020-03730-w","volume":"469","author":"K Minami","year":"2020","unstructured":"Minami K, Ueda N, Ishimoto K et al (2020) Lysophosphatidic acid receptor-2 (LPA(2))-mediated signaling enhances chemoresistance in melanoma cells treated with anticancer drugs. Mol Cell Biochem 469:89\u201395","journal-title":"Mol Cell Biochem"},{"key":"820_CR3","doi-asserted-by":"publisher","first-page":"108421","DOI":"10.1016\/j.pharmthera.2023.108421","volume":"246","author":"K Yanagida","year":"2023","unstructured":"Yanagida K, Shimizu T (2023) Lysophosphatidic acid, a simple phospholipid with myriad functions. Pharmacol Ther 246:108421","journal-title":"Pharmacol Ther"},{"key":"820_CR4","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1042\/BST20110608","volume":"40","author":"M Gotoh","year":"2012","unstructured":"Gotoh M, Fujiwara Y, Yue J et al (2012) Controlling cancer through the autotaxin-lysophosphatidic acid receptor axis. Biochem Soc Trans 40:31\u201336","journal-title":"Biochem Soc Trans"},{"key":"820_CR5","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1146\/annurev.pharmtox.010909.105753","volume":"50","author":"JW Choi","year":"2010","unstructured":"Choi JW, Herr DR, Noguchi K et al (2010) LPA receptors: subtypes and biological actions. Annu Rev Pharmacol Toxicol 50:157\u2013186","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"820_CR6","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.bbalip.2008.04.013","volume":"1781","author":"FT Lin","year":"2008","unstructured":"Lin FT, Lai YJ (2008) Regulation of the LPA2 receptor signaling through the carboxyl-terminal tail-mediated protein-protein interactions. Biochim Biophys Acta 1781:558\u2013562","journal-title":"Biochim Biophys Acta"},{"key":"820_CR7","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.2353\/ajpath.2009.080160","volume":"174","author":"MY Xu","year":"2009","unstructured":"Xu MY, Porte J, Knox AJ et al (2009) Lysophosphatidic acid induces alphavbeta6 integrin-mediated TGF-beta activation via the LPA2 receptor and the small G protein G alpha(q). Am J Pathol 174:1264\u20131279","journal-title":"Am J Pathol"},{"key":"820_CR8","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1016\/j.ajpath.2012.06.035","volume":"181","author":"H Geng","year":"2012","unstructured":"Geng H, Lan R, Singha PK et al (2012) Lysophosphatidic acid increases proximal tubule cell secretion of profibrotic cytokines PDGF-B and CTGF through LPA2- and Galphaq-mediated Rho and alphavbeta6 integrin-dependent activation of TGF-beta. Am J Pathol 181:1236\u20131249","journal-title":"Am J Pathol"},{"key":"820_CR9","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1165\/rcmb.2013-0070OC","volume":"49","author":"LS Huang","year":"2013","unstructured":"Huang LS, Fu P, Patel P et al (2013) Lysophosphatidic acid receptor-2 deficiency confers protection against bleomycin-induced lung injury and fibrosis in mice. Am J Respir Cell Mol Biol 49:912\u2013922","journal-title":"Am J Respir Cell Mol Biol"},{"key":"820_CR10","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.bmcl.2007.12.024","volume":"18","author":"HP Beck","year":"2008","unstructured":"Beck HP, Kohn T, Rubenstein S et al (2008) Discovery of potent LPA2 (EDG4) antagonists as potential anticancer agents. Bioorg Med Chem Lett 18:1037\u20131041","journal-title":"Bioorg Med Chem Lett"},{"key":"820_CR11","doi-asserted-by":"publisher","first-page":"6207","DOI":"10.1016\/j.bmc.2008.04.035","volume":"16","author":"JI Fells","year":"2008","unstructured":"Fells JI, Tsukahara R, Fujiwara Y et al (2008) Identification of non-lipid LPA3 antagonists by virtual screening. Bioorg Med Chem 16:6207\u20136217","journal-title":"Bioorg Med Chem"},{"key":"820_CR12","doi-asserted-by":"publisher","first-page":"10956","DOI":"10.1021\/acs.jmedchem.2c00046","volume":"65","author":"N Khiar-Fernandez","year":"2022","unstructured":"Khiar-Fernandez N, Zian D, Vazquez-Villa H et al (2022) Novel antagonist of the type 2 lysophosphatidic acid receptor (LPA(2)), UCM-14216, ameliorates spinal cord injury in mice. J Med Chem 65:10956\u201310974","journal-title":"J Med Chem"},{"key":"820_CR13","doi-asserted-by":"publisher","first-page":"5622","DOI":"10.1021\/acs.jmedchem.2c02087","volume":"66","author":"E Armani","year":"2023","unstructured":"Armani E, Rizzi A, Iotti N et al (2023) Discovery of a potent, selective, and orally bioavailable tool compound for probing the role of lysophosphatidic acid type 2 receptor antagonists in fibrotic disorders. J Med Chem 66:5622\u20135656","journal-title":"J Med Chem"},{"key":"820_CR14","doi-asserted-by":"publisher","first-page":"4130","DOI":"10.1021\/jm00050a010","volume":"37","author":"G Klebe","year":"1994","unstructured":"Klebe G, Abraham U, Mietzner T (1994) Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity. J Med Chem 37:4130\u20134146","journal-title":"J Med Chem"},{"key":"820_CR15","doi-asserted-by":"publisher","first-page":"5959","DOI":"10.1021\/ja00226a005","volume":"110","author":"RD Cramer","year":"1988","unstructured":"Cramer RD, Patterson DE, Bunce JD (1988) Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. J Am Chem Soc 110:5959\u20135967","journal-title":"J Am Chem Soc"},{"key":"820_CR16","doi-asserted-by":"publisher","first-page":"923","DOI":"10.2174\/092986711794927702","volume":"18","author":"L Zhang","year":"2011","unstructured":"Zhang L, Tsai KC, Du L et al (2011) How to generate reliable and predictive CoMFA models. Curr Med Chem 18:923\u2013930","journal-title":"Curr Med Chem"},{"key":"820_CR17","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1021\/ci800240m","volume":"48","author":"A Kapou","year":"2008","unstructured":"Kapou A, Benetis NP, Durdagi S et al (2008) 3D QSAR\/CoMFA and CoMSIA studies on antileukemic steroidal esters coupled with conformationally flexible nitrogen mustards. J Chem Inf Model 48:2254\u20132264","journal-title":"J Chem Inf Model"},{"key":"820_CR18","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2174\/156802610790232260","volume":"10","author":"J Verma","year":"2010","unstructured":"Verma J, Khedkar VM, Coutinho EC (2010) 3D-QSAR in drug design\u2013a review. Curr Top Med Chem 10:95\u2013115","journal-title":"Curr Top Med Chem"},{"key":"820_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-61779-588-6","volume-title":"Homology modeling: methods and protocols","author":"AJW Orry","year":"2012","unstructured":"Orry AJW, Abagyan R (2012) Homology modeling: methods and protocols. Humana, Springer, New York"},{"key":"820_CR20","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1016\/j.cell.2015.06.002","volume":"161","author":"JE Chrencik","year":"2015","unstructured":"Chrencik JE, Roth CB, Terakado M et al (2015) Crystal structure of antagonist bound human lysophosphatidic acid receptor 1. Cell 161:1633\u20131643","journal-title":"Cell"},{"key":"820_CR21","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/s41467-022-28417-2","volume":"13","author":"S Liu","year":"2022","unstructured":"Liu S, Paknejad N, Zhu L et al (2022) Differential activation mechanisms of lipid GPCRs by lysophosphatidic acid and sphingosine 1-phosphate. Nat Commun 13:731","journal-title":"Nat Commun"},{"key":"820_CR22","doi-asserted-by":"publisher","first-page":"e2117716119","DOI":"10.1073\/pnas.2117716119","volume":"119","author":"L Yu","year":"2022","unstructured":"Yu L, He L, Gan B et al (2022) Structural insights into sphingosine-1-phosphate receptor activation. Proc Natl Acad Sci U S A 119:e2117716119","journal-title":"Proc Natl Acad Sci U S A"},{"key":"820_CR23","doi-asserted-by":"publisher","first-page":"W422","DOI":"10.1093\/nar\/gkae236","volume":"52","author":"L Fu","year":"2024","unstructured":"Fu L, Shi S, Yi J et al (2024) ADMETlab 3.0: an updated comprehensive online ADMET prediction platform enhanced with broader coverage, improved performance, API functionality and decision support. Nucleic Acids Res 52:W422\u2013W431","journal-title":"Nucleic Acids Res"},{"key":"820_CR24","doi-asserted-by":"publisher","first-page":"4019","DOI":"10.2174\/092986711796957220","volume":"18","author":"HX Zhang","year":"2011","unstructured":"Zhang HX, Li Y, Wang X et al (2011) Insight into the structural requirements of benzothiadiazine scaffold-based derivatives as hepatitis C virus NS5B polymerase inhibitors using 3D-QSAR, molecular docking and molecular dynamics. Curr Med Chem 18:4019\u20134028","journal-title":"Curr Med Chem"},{"key":"820_CR25","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/BF00124364","volume":"7","author":"BL Bush","year":"1993","unstructured":"Bush BL, Nachbar RB Jr. (1993) Sample-distance partial least squares: PLS optimized for many variables, with application to CoMFA. J Comput Aided Mol Des 7:587\u2013619","journal-title":"J Comput Aided Mol Des"},{"key":"820_CR26","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.3390\/molecules14051660","volume":"14","author":"P Pratim Roy","year":"2009","unstructured":"Pratim Roy P, Paul S, Mitra I et al (2009) On two novel parameters for validation of predictive QSAR models. Molecules 14:1660\u20131701","journal-title":"Molecules"},{"key":"820_CR27","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1110\/ps.062416606","volume":"15","author":"MY Shen","year":"2006","unstructured":"Shen MY, Sali A (2006) Statistical potential for assessment and prediction of protein structures. Protein Sci 15:2507\u20132524","journal-title":"Protein Sci"},{"key":"820_CR28","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/381272a0","volume":"381","author":"RW Hooft","year":"1996","unstructured":"Hooft RW, Vriend G, Sander C et al (1996) Errors in protein structures. Nature 381:272","journal-title":"Nature"},{"key":"820_CR29","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1021\/acscentsci.8b00718","volume":"5","author":"R Menichetti","year":"2019","unstructured":"Menichetti R, Kanekal KH, Bereau T (2019) Drug-membrane permeability across chemical space. ACS Cent Sci 5:290\u2013298","journal-title":"ACS Cent Sci"},{"key":"820_CR30","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S1093-3263(01)00123-1","volume":"20","author":"A Golbraikh","year":"2002","unstructured":"Golbraikh A, Tropsha A (2002) Beware of q2! J Mol Graph Model 20:269\u2013276","journal-title":"J Mol Graph Model"},{"key":"820_CR31","unstructured":"Shankar G, Solow-Cordero D, Spencer JV et al (2003) Methods of treating conditions associated with an EDG receptor. WO2003062392"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-026-00820-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10822-026-00820-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-026-00820-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T07:05:18Z","timestamp":1777878318000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10822-026-00820-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,4]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["820"],"URL":"https:\/\/doi.org\/10.1007\/s10822-026-00820-7","relation":{},"ISSN":["1573-4951"],"issn-type":[{"value":"1573-4951","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,4]]},"assertion":[{"value":"19 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"112"}}